Global Asthma Therapeutics Market Insights and Forecast to 2028

Global Asthma Therapeutics Market Insights and Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Asthma Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Inhalation
1.2.3 Parenteral
1.2.4 Oral
1.3 Market by Application
1.3.1 Global Asthma Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Asthma Therapeutics Market Perspective (2017-2028)
2.2 Asthma Therapeutics Growth Trends by Region
2.2.1 Asthma Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Asthma Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Asthma Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Asthma Therapeutics Market Dynamics
2.3.1 Asthma Therapeutics Industry Trends
2.3.2 Asthma Therapeutics Market Drivers
2.3.3 Asthma Therapeutics Market Challenges
2.3.4 Asthma Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Asthma Therapeutics Players by Revenue
3.1.1 Global Top Asthma Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Asthma Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Asthma Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Asthma Therapeutics Revenue
3.4 Global Asthma Therapeutics Market Concentration Ratio
3.4.1 Global Asthma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Asthma Therapeutics Revenue in 2021
3.5 Asthma Therapeutics Key Players Head office and Area Served
3.6 Key Players Asthma Therapeutics Product Solution and Service
3.7 Date of Enter into Asthma Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Asthma Therapeutics Breakdown Data by Type
4.1 Global Asthma Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Asthma Therapeutics Forecasted Market Size by Type (2023-2028)
5 Asthma Therapeutics Breakdown Data by Application
5.1 Global Asthma Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Asthma Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Asthma Therapeutics Market Size (2017-2028)
6.2 North America Asthma Therapeutics Market Size by Type
6.2.1 North America Asthma Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Asthma Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Asthma Therapeutics Market Share by Type (2017-2028)
6.3 North America Asthma Therapeutics Market Size by Application
6.3.1 North America Asthma Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Asthma Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Asthma Therapeutics Market Share by Application (2017-2028)
6.4 North America Asthma Therapeutics Market Size by Country
6.4.1 North America Asthma Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Asthma Therapeutics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Asthma Therapeutics Market Size (2017-2028)
7.2 Europe Asthma Therapeutics Market Size by Type
7.2.1 Europe Asthma Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Asthma Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Asthma Therapeutics Market Share by Type (2017-2028)
7.3 Europe Asthma Therapeutics Market Size by Application
7.3.1 Europe Asthma Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Asthma Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Asthma Therapeutics Market Share by Application (2017-2028)
7.4 Europe Asthma Therapeutics Market Size by Country
7.4.1 Europe Asthma Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Asthma Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Asthma Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Asthma Therapeutics Market Size by Type
8.2.1 Asia-Pacific Asthma Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Asthma Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Asthma Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Asthma Therapeutics Market Size by Application
8.3.1 Asia-Pacific Asthma Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Asthma Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Asthma Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Asthma Therapeutics Market Size by Region
8.4.1 Asia-Pacific Asthma Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Asthma Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Asthma Therapeutics Market Size (2017-2028)
9.2 Latin America Asthma Therapeutics Market Size by Type
9.2.1 Latin America Asthma Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Asthma Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Asthma Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Asthma Therapeutics Market Size by Application
9.3.1 Latin America Asthma Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Asthma Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Asthma Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Asthma Therapeutics Market Size by Country
9.4.1 Latin America Asthma Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Asthma Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Asthma Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Asthma Therapeutics Market Size by Type
10.2.1 Middle East & Africa Asthma Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Asthma Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Asthma Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Asthma Therapeutics Market Size by Application
10.3.1 Middle East & Africa Asthma Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Asthma Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Asthma Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Asthma Therapeutics Market Size by Country
10.4.1 Middle East & Africa Asthma Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Asthma Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Asthma Therapeutics Introduction
11.1.4 AstraZeneca Revenue in Asthma Therapeutics Business (2017-2022)
11.1.5 AstraZeneca Recent Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Asthma Therapeutics Introduction
11.2.4 Boehringer Ingelheim Revenue in Asthma Therapeutics Business (2017-2022)
11.2.5 Boehringer Ingelheim Recent Developments
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Details
11.3.2 F. Hoffmann-La Roche Business Overview
11.3.3 F. Hoffmann-La Roche Asthma Therapeutics Introduction
11.3.4 F. Hoffmann-La Roche Revenue in Asthma Therapeutics Business (2017-2022)
11.3.5 F. Hoffmann-La Roche Recent Developments
11.4 GSK
11.4.1 GSK Company Details
11.4.2 GSK Business Overview
11.4.3 GSK Asthma Therapeutics Introduction
11.4.4 GSK Revenue in Asthma Therapeutics Business (2017-2022)
11.4.5 GSK Recent Developments
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Asthma Therapeutics Introduction
11.5.4 Merck Revenue in Asthma Therapeutics Business (2017-2022)
11.5.5 Merck Recent Developments
11.6 Horizon Pharma
11.6.1 Horizon Pharma Company Details
11.6.2 Horizon Pharma Business Overview
11.6.3 Horizon Pharma Asthma Therapeutics Introduction
11.6.4 Horizon Pharma Revenue in Asthma Therapeutics Business (2017-2022)
11.6.5 Horizon Pharma Recent Developments
11.7 Mitsubishi Tanabe Pharma
11.7.1 Mitsubishi Tanabe Pharma Company Details
11.7.2 Mitsubishi Tanabe Pharma Business Overview
11.7.3 Mitsubishi Tanabe Pharma Asthma Therapeutics Introduction
11.7.4 Mitsubishi Tanabe Pharma Revenue in Asthma Therapeutics Business (2017-2022)
11.7.5 Mitsubishi Tanabe Pharma Recent Developments
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Asthma Therapeutics Introduction
11.8.4 Sanofi Revenue in Asthma Therapeutics Business (2017-2022)
11.8.5 Sanofi Recent Developments
11.9 Mundipharma
11.9.1 Mundipharma Company Details
11.9.2 Mundipharma Business Overview
11.9.3 Mundipharma Asthma Therapeutics Introduction
11.9.4 Mundipharma Revenue in Asthma Therapeutics Business (2017-2022)
11.9.5 Mundipharma Recent Developments
11.10 Nycomed
11.10.1 Nycomed Company Details
11.10.2 Nycomed Business Overview
11.10.3 Nycomed Asthma Therapeutics Introduction
11.10.4 Nycomed Revenue in Asthma Therapeutics Business (2017-2022)
11.10.5 Nycomed Recent Developments
11.11 Kissei Pharmaceutical
11.11.1 Kissei Pharmaceutical Company Details
11.11.2 Kissei Pharmaceutical Business Overview
11.11.3 Kissei Pharmaceutical Asthma Therapeutics Introduction
11.11.4 Kissei Pharmaceutical Revenue in Asthma Therapeutics Business (2017-2022)
11.11.5 Kissei Pharmaceutical Recent Developments
11.12 ALK-Abello
11.12.1 ALK-Abello Company Details
11.12.2 ALK-Abello Business Overview
11.12.3 ALK-Abello Asthma Therapeutics Introduction
11.12.4 ALK-Abello Revenue in Asthma Therapeutics Business (2017-2022)
11.12.5 ALK-Abello Recent Developments
11.13 Array BioPharma
11.13.1 Array BioPharma Company Details
11.13.2 Array BioPharma Business Overview
11.13.3 Array BioPharma Asthma Therapeutics Introduction
11.13.4 Array BioPharma Revenue in Asthma Therapeutics Business (2017-2022)
11.13.5 Array BioPharma Recent Developments
11.14 SAMA Pharmaceuticals
11.14.1 SAMA Pharmaceuticals Company Details
11.14.2 SAMA Pharmaceuticals Business Overview
11.14.3 SAMA Pharmaceuticals Asthma Therapeutics Introduction
11.14.4 SAMA Pharmaceuticals Revenue in Asthma Therapeutics Business (2017-2022)
11.14.5 SAMA Pharmaceuticals Recent Developments
11.15 Whanin Pharmaceutical
11.15.1 Whanin Pharmaceutical Company Details
11.15.2 Whanin Pharmaceutical Business Overview
11.15.3 Whanin Pharmaceutical Asthma Therapeutics Introduction
11.15.4 Whanin Pharmaceutical Revenue in Asthma Therapeutics Business (2017-2022)
11.15.5 Whanin Pharmaceutical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Asthma Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Inhalation
Table 3. Key Players of Parenteral
Table 4. Key Players of Oral
Table 5. Global Asthma Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Asthma Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Asthma Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Asthma Therapeutics Market Share by Region (2017-2022)
Table 9. Global Asthma Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Asthma Therapeutics Market Share by Region (2023-2028)
Table 11. Asthma Therapeutics Market Trends
Table 12. Asthma Therapeutics Market Drivers
Table 13. Asthma Therapeutics Market Challenges
Table 14. Asthma Therapeutics Market Restraints
Table 15. Global Asthma Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Asthma Therapeutics Revenue Share by Players (2017-2022)
Table 17. Global Top Asthma Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Asthma Therapeutics as of 2021)
Table 18. Ranking of Global Top Asthma Therapeutics Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Asthma Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Asthma Therapeutics Product Solution and Service
Table 22. Date of Enter into Asthma Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Asthma Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Asthma Therapeutics Revenue Market Share by Type (2017-2022)
Table 26. Global Asthma Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Asthma Therapeutics Revenue Market Share by Type (2023-2028)
Table 28. Global Asthma Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Asthma Therapeutics Revenue Share by Application (2017-2022)
Table 30. Global Asthma Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Asthma Therapeutics Revenue Share by Application (2023-2028)
Table 32. North America Asthma Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Asthma Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Asthma Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Asthma Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Asthma Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Asthma Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Asthma Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Asthma Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Asthma Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Asthma Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Asthma Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Asthma Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Asthma Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Asthma Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Asthma Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Asthma Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Asthma Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Asthma Therapeutics Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Asthma Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Asthma Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Asthma Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Asthma Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Asthma Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Asthma Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Asthma Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Asthma Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Asthma Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Asthma Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Asthma Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Asthma Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 62. AstraZeneca Company Details
Table 63. AstraZeneca Business Overview
Table 64. AstraZeneca Asthma Therapeutics Product
Table 65. AstraZeneca Revenue in Asthma Therapeutics Business (2017-2022) & (US$ Million)
Table 66. AstraZeneca Recent Developments
Table 67. Boehringer Ingelheim Company Details
Table 68. Boehringer Ingelheim Business Overview
Table 69. Boehringer Ingelheim Asthma Therapeutics Product
Table 70. Boehringer Ingelheim Revenue in Asthma Therapeutics Business (2017-2022) & (US$ Million)
Table 71. Boehringer Ingelheim Recent Developments
Table 72. F. Hoffmann-La Roche Company Details
Table 73. F. Hoffmann-La Roche Business Overview
Table 74. F. Hoffmann-La Roche Asthma Therapeutics Product
Table 75. F. Hoffmann-La Roche Revenue in Asthma Therapeutics Business (2017-2022) & (US$ Million)
Table 76. F. Hoffmann-La Roche Recent Developments
Table 77. GSK Company Details
Table 78. GSK Business Overview
Table 79. GSK Asthma Therapeutics Product
Table 80. GSK Revenue in Asthma Therapeutics Business (2017-2022) & (US$ Million)
Table 81. GSK Recent Developments
Table 82. Merck Company Details
Table 83. Merck Business Overview
Table 84. Merck Asthma Therapeutics Product
Table 85. Merck Revenue in Asthma Therapeutics Business (2017-2022) & (US$ Million)
Table 86. Merck Recent Developments
Table 87. Horizon Pharma Company Details
Table 88. Horizon Pharma Business Overview
Table 89. Horizon Pharma Asthma Therapeutics Product
Table 90. Horizon Pharma Revenue in Asthma Therapeutics Business (2017-2022) & (US$ Million)
Table 91. Horizon Pharma Recent Developments
Table 92. Mitsubishi Tanabe Pharma Company Details
Table 93. Mitsubishi Tanabe Pharma Business Overview
Table 94. Mitsubishi Tanabe Pharma Asthma Therapeutics Product
Table 95. Mitsubishi Tanabe Pharma Revenue in Asthma Therapeutics Business (2017-2022) & (US$ Million)
Table 96. Mitsubishi Tanabe Pharma Recent Developments
Table 97. Sanofi Company Details
Table 98. Sanofi Business Overview
Table 99. Sanofi Asthma Therapeutics Product
Table 100. Sanofi Revenue in Asthma Therapeutics Business (2017-2022) & (US$ Million)
Table 101. Sanofi Recent Developments
Table 102. Mundipharma Company Details
Table 103. Mundipharma Business Overview
Table 104. Mundipharma Asthma Therapeutics Product
Table 105. Mundipharma Revenue in Asthma Therapeutics Business (2017-2022) & (US$ Million)
Table 106. Mundipharma Recent Developments
Table 107. Nycomed Company Details
Table 108. Nycomed Business Overview
Table 109. Nycomed Asthma Therapeutics Product
Table 110. Nycomed Revenue in Asthma Therapeutics Business (2017-2022) & (US$ Million)
Table 111. Nycomed Recent Developments
Table 112. Kissei Pharmaceutical Company Details
Table 113. Kissei Pharmaceutical Business Overview
Table 114. Kissei Pharmaceutical Asthma Therapeutics Product
Table 115. Kissei Pharmaceutical Revenue in Asthma Therapeutics Business (2017-2022) & (US$ Million)
Table 116. Kissei Pharmaceutical Recent Developments
Table 117. ALK-Abello Company Details
Table 118. ALK-Abello Business Overview
Table 119. ALK-Abello Asthma Therapeutics Product
Table 120. ALK-Abello Revenue in Asthma Therapeutics Business (2017-2022) & (US$ Million)
Table 121. ALK-Abello Recent Developments
Table 122. Array BioPharma Company Details
Table 123. Array BioPharma Business Overview
Table 124. Array BioPharma Asthma Therapeutics Product
Table 125. Array BioPharma Revenue in Asthma Therapeutics Business (2017-2022) & (US$ Million)
Table 126. Array BioPharma Recent Developments
Table 127. SAMA Pharmaceuticals Company Details
Table 128. SAMA Pharmaceuticals Business Overview
Table 129. SAMA Pharmaceuticals Asthma Therapeutics Product
Table 130. SAMA Pharmaceuticals Revenue in Asthma Therapeutics Business (2017-2022) & (US$ Million)
Table 131. SAMA Pharmaceuticals Recent Developments
Table 132. Whanin Pharmaceutical Company Details
Table 133. Whanin Pharmaceutical Business Overview
Table 134. Whanin Pharmaceutical Asthma Therapeutics Product
Table 135. Whanin Pharmaceutical Revenue in Asthma Therapeutics Business (2017-2022) & (US$ Million)
Table 136. Whanin Pharmaceutical Recent Developments
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Asthma Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. Inhalation Features
Figure 3. Parenteral Features
Figure 4. Oral Features
Figure 5. Global Asthma Therapeutics Market Share by Application: 2021 VS 2028
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Asthma Therapeutics Report Years Considered
Figure 9. Global Asthma Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Asthma Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Asthma Therapeutics Market Share by Region: 2021 VS 2028
Figure 12. Global Asthma Therapeutics Market Share by Players in 2021
Figure 13. Global Top Asthma Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Asthma Therapeutics as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Asthma Therapeutics Revenue in 2021
Figure 15. North America Asthma Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Asthma Therapeutics Market Size Market Share by Type (2017-2028)
Figure 17. North America Asthma Therapeutics Market Size Market Share by Application (2017-2028)
Figure 18. North America Asthma Therapeutics Market Size Share by Country (2017-2028)
Figure 19. United States Asthma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Asthma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Asthma Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Asthma Therapeutics Market Size Market Share by Type (2017-2028)
Figure 23. Europe Asthma Therapeutics Market Size Market Share by Application (2017-2028)
Figure 24. Europe Asthma Therapeutics Market Size Share by Country (2017-2028)
Figure 25. Germany Asthma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Asthma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Asthma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Asthma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Asthma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Asthma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Asthma Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Asthma Therapeutics Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Asthma Therapeutics Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Asthma Therapeutics Market Size Share by Region (2017-2028)
Figure 35. China Asthma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Asthma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Asthma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Asthma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Asthma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Asthma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Asthma Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Asthma Therapeutics Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Asthma Therapeutics Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Asthma Therapeutics Market Size Share by Country (2017-2028)
Figure 45. Mexico Asthma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Asthma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Asthma Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Asthma Therapeutics Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Asthma Therapeutics Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Asthma Therapeutics Market Size Share by Country (2017-2028)
Figure 51. Turkey Asthma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Asthma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Asthma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. AstraZeneca Revenue Growth Rate in Asthma Therapeutics Business (2017-2022)
Figure 55. Boehringer Ingelheim Revenue Growth Rate in Asthma Therapeutics Business (2017-2022)
Figure 56. F. Hoffmann-La Roche Revenue Growth Rate in Asthma Therapeutics Business (2017-2022)
Figure 57. GSK Revenue Growth Rate in Asthma Therapeutics Business (2017-2022)
Figure 58. Merck Revenue Growth Rate in Asthma Therapeutics Business (2017-2022)
Figure 59. Horizon Pharma Revenue Growth Rate in Asthma Therapeutics Business (2017-2022)
Figure 60. Mitsubishi Tanabe Pharma Revenue Growth Rate in Asthma Therapeutics Business (2017-2022)
Figure 61. Sanofi Revenue Growth Rate in Asthma Therapeutics Business (2017-2022)
Figure 62. Mundipharma Revenue Growth Rate in Asthma Therapeutics Business (2017-2022)
Figure 63. Nycomed Revenue Growth Rate in Asthma Therapeutics Business (2017-2022)
Figure 64. Kissei Pharmaceutical Revenue Growth Rate in Asthma Therapeutics Business (2017-2022)
Figure 65. ALK-Abello Revenue Growth Rate in Asthma Therapeutics Business (2017-2022)
Figure 66. Array BioPharma Revenue Growth Rate in Asthma Therapeutics Business (2017-2022)
Figure 67. SAMA Pharmaceuticals Revenue Growth Rate in Asthma Therapeutics Business (2017-2022)
Figure 68. Whanin Pharmaceutical Revenue Growth Rate in Asthma Therapeutics Business (2017-2022)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Montelukast Sodium Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134

According to our LPI (LP Information) latest study, the global Montelukast Sodium market size was valued at US$ 336.3 million in 2023. With growing demand in downstream market, the Montelukast Sodium is forecast to a readjusted size of US$ 815.4 million by 2030 with a CAGR of 13.5% during review period. The research report highlights the growth potential of the global Montelukast Sodium market. Montelukast Sodium are expected to show stable growth in the future market. However, product d......

Global Montelukast Sodium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 132

According to our (Global Info Research) latest study, the global Montelukast Sodium market size was valued at USD 353.8 million in 2023 and is forecast to a readjusted size of USD 803.8 million by 2030 with a CAGR of 12.4% during review period. Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chr......

Asthma Therapeutics - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 114

The global Asthma Therapeutics market size is expected to reach US$ 27800 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Asthma Therapeutics in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling Asthma Therapeutics market. Inhalation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in......

Global Asthma Therapeutics Market Research Report 2023, Forecast to 2028

Published: 15-Dec-2023        Price: US 2680 Onwards        Pages: 163

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......

Global Budesonide Aerosol Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 146

Report Overview: The Global Budesonide Aerosol Market Size was estimated at USD 7996.70 million in 2022 and is projected to reach USD 41912.84 million by 2029, exhibiting a CAGR of 26.70% during the forecast period. This report provides a deep insight into the global Budesonide Aerosol market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key marke......

Global Asthma Therapeutics Professional Survey Report 2023, Forecast to 2028

Published: 15-Dec-2023        Price: US 3280 Onwards        Pages: 139

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......

Global Montelukast Sodium Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 144

Report Overview: Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis. The Global Montelukast Sodium Market Size was estimated at USD 816.70 million in 2022 and is projected to reach USD 1921.37 million by 20......

Global Doxofylline (API) Market Research Report 2023

Published: 28-Nov-2023        Price: US 2900 Onwards        Pages: 88

Doxofylline (also known as doxophylline) is a phosphodiesterase inhibiting bronchodilator used in The treatment of chronic respiratory diseases such as asthma and COPD. Like theophylline, it is a xanthine derivative. According to QYResearch's new survey, global Doxofylline (API) market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with The CAGR of % during The period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Uk......

Global Montelukast Sodium Market Research Report 2023, Forecast to 2028

Published: 21-Nov-2023        Price: US 2680 Onwards        Pages: 164

Montelukast sodium is an organic sodium salt. Montelukast is an orally available leukotriene receptor antagonist which is widely used for the prophylaxis and chronic treatment of asthma and has been linked to rare cases of clinically apparent liver injury. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs